Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Scientists Look Into Why Most Alzheimer's Patients Are Women

June 29, 2015 9:42 am | by Lauren Neergaard, AP Medical writer - Associated Press | News | Comments

Nearly two-thirds of Americans with Alzheimer's disease are women, and now some scientists are questioning the long-held assumption that it's just because they tend to live longer than men. Read more..


TSRI and Biotech Partners Find New Antibody Weapons against Marburg Virus

June 29, 2015 9:34 am | by The Scripps Research Institute | News | Comments

A new study led by scientists at The Scripps Research Institute (TSRI) identifies new immune molecules that protect against deadly Marburg virus, a relative of Ebola virus. The research provides ingredients needed to develop treatments for future Marburg outbreaks. Read more...


Turning the Tables on Cancer

June 29, 2015 9:29 am | by Shari Roan, UCLA | News | Comments

A new class of immunotherapies is enlisting the body's own immune system to fight cancer. Read more...


Blood Test IDs Pancreatic Cancer in 250 of 250 Patients

June 29, 2015 9:18 am | by Cynthia Fox, Science Editor | Articles | Comments

A new blood test identified pancreatic cancer with 100 percent accuracy in 250 of 250 patients, said a recent report in Nature. The test found pancreatic exosomes in blood via the biomarker GPC1. It distinguished early-stage cancer from late-stage cancer—with zero false positives/negatives. It predicted survival. Read more...


Novartis Acquires U.S. Biotech Firm Spinifex

June 29, 2015 8:45 am | by The Associated Press | News | Comments

Novartis didn't disclose financial details Monday of the agreement. Read more...


Major Step for Implantable Drug Delivery Device

June 29, 2015 8:41 am | by MIT | News | Comments

An implantable, microchip-based device may soon replace the injections and pills now needed to treat chronic diseases. Read more...


Ascletis Files Clinical Trial Applications for Hepatitis C Drugs in China, Taiwan

June 29, 2015 8:30 am | News | Comments

Ascletis is now the first Chinese company to file clinical trial applications in China for an IFN-free regimen. Read more...


DNA Damage Linked with Dementia

June 29, 2015 8:29 am | by University of Sheffield | News | Comments

High levels of DNA damage in nerve cells can lead to dementia. Read more...


EU Recommends Approval of Roche's Pre-Surgery Breast Cancer Treatment

June 29, 2015 8:29 am | News | Comments

The majority of breast cancer cases are diagnosed at an early stage of the disease, before the cancer has spread to other parts of the body. Read more...


EU Recommends Approval for Alexion's Rare Disease Drugs

June 29, 2015 8:26 am | News | Comments

The drugs are called Strensiq and Kanuma.


Allergan Layoffs Done at Irvine Location; Kythera Cuts in Question

June 26, 2015 1:35 pm | by Ryan Bushey, Associate Editor | Articles | Comments

The CEO of Allergan discussed the future of his company after the completion of the Actavis merger. Read more...


Drug Discovery Spotlight: ASCO’s Cancer Drugs Rating Scale; Hepatitis C Drug Patent Rejected in China

June 26, 2015 12:59 pm | by Stephanie Guzowski, Editor | News | Comments

The American Society of Clinical Oncology said it would provide a rating scale for cancer drugs, and now it’s delivered — and not all the score results are assuring. Pharma’s next five years look promising, according to an industry report. Read more...


California Vaccine Bill Clears Legislative Hurdle

June 26, 2015 10:43 am | by Seth Augenstein, Digital Reporter | News | Comments

A split California Assembly approved a bill that would require nearly all public school kids to get basic vaccines Thursday. The bill passed on a bipartisan 46 to 30 vote and, if signed by the governor, would give California one of the strictest vaccine requirements, by eliminating the “personal belief” exemption used by anti-vaccine parents. Read more...


Janssen Schizophrenia Treatment Now Commercially Available

June 26, 2015 10:37 am | News | Comments

The first schizophrenia treatment to be taken just four times a year – with dosing measured in seasons, not days – is now available in the United States. The three-month dosing interval of Invega Trinza (paliperidone palmitate) offers a new paradigm for treating patients with schizophrenia. Read more...


Delivering Drugs to the Right Place

June 26, 2015 9:27 am | by UC Santa Barbara | News | Comments

For the 12 million people worldwide who suffer from polycystic kidney disease (PKD), an inherited disorder with no known cure, a new treatment option may be on the horizon. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.